Arsenic
In clinical developmentAlso known as As - Arsenic.
Recent clinical, regulatory, research and industry developments relating to this drug.
Mitigation of arsenic toxicity in natural waters using a bacterial biomineralizing system
Burned-home soils showed uneven lead, arsenic contamination after Los Angeles wildfires
Arsenic: A Global Environmental Challenge.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes2
Journals, researchers & institutions
- Annual review of pharmacology and toxicology1
- Chen QY1
- Costa M1
- New York University School of Medicine1
- School of Basic Medical Sciences1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials